← Back to Screener
Tactile Systems Technology, Inc. (TCMD)
Price$25.13
Favorite Metrics
Price vs S&P 500 (26W)66.15%
Price vs S&P 500 (4W)-12.04%
Market Capitalization$571.72M
P/E Ratio (Annual)29.95x
All Metrics
P/CF (Annual)13.35x
Book Value / Share (Quarterly)$9.76
P/TBV (Annual)3.60x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)10.11%
Cash Flow / Share (Quarterly)$1.79
Price vs S&P 500 (YTD)-15.23%
Gross Margin (TTM)50.79%
Net Profit Margin (TTM)5.79%
EPS (TTM)$0.83
10-Day Avg Trading Volume0.24M
EPS Excl Extra (TTM)$0.83
Revenue Growth (5Y)11.99%
EPS (Annual)$0.82
ROI (Annual)8.72%
Gross Margin (Annual)50.79%
Net Profit Margin (5Y Avg)1.81%
Cash / Share (Quarterly)$4.42
P/E Basic Excl Extra (TTM)29.95x
Revenue Growth QoQ (YoY)21.04%
P/E Normalized (Annual)29.95x
ROA (Last FY)6.97%
Revenue Growth TTM (YoY)12.47%
EBITD / Share (TTM)$1.37
ROE (5Y Avg)1.47%
Operating Margin (TTM)8.89%
Cash Flow / Share (Annual)$1.79
P/B Ratio2.61x
P/B Ratio (Quarterly)2.96x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.48x
ROA (TTM)7.03%
EPS Growth QoQ (YoY)14.51%
EV / EBITDA (TTM)15.39x
EPS Incl Extra (Annual)$0.82
Current Ratio (Annual)4.03x
Quick Ratio (Quarterly)3.49x
3-Month Avg Trading Volume0.33M
52-Week Price Return89.18%
EV / Free Cash Flow (Annual)12.12x
P/E Incl Extra (TTM)29.95x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$8.01
P/S Ratio (Annual)1.74x
Asset Turnover (Annual)1.20x
52-Week High$37.77
Operating Margin (5Y Avg)3.40%
EPS Excl Extra (Annual)$0.82
CapEx CAGR (5Y)2.05%
Tangible BV CAGR (5Y)7.86%
26-Week Price Return70.13%
Quick Ratio (Annual)3.49x
13-Week Price Return-15.13%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.03x
Enterprise Value$488.272
Revenue / Share Growth (5Y)7.85%
Asset Turnover (TTM)1.21x
Book Value / Share Growth (5Y)8.80%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)9.92x
Pretax Margin (Annual)9.51%
Cash / Share (Annual)$4.42
3-Month Return Std Dev55.15%
Gross Margin (5Y Avg)49.45%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)130.27%
EBITDA Interim CAGR (5Y)16.91%
ROE (Last FY)8.72%
EPS Basic Excl Extra (Annual)$0.82
P/FCF (TTM)14.20x
Receivables Turnover (TTM)7.42x
EV / Free Cash Flow (TTM)12.12x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.83
Receivables Turnover (Annual)7.42x
ROI (TTM)8.73%
P/S Ratio (TTM)1.74x
Pretax Margin (5Y Avg)3.18%
Revenue / Share (Annual)$14.15
Tangible BV / Share (Annual)$8.01
Forward P/E22.04x
Free OCF CAGR (5Y)140.56%
Price vs S&P 500 (52W)59.35%
P/E Ratio (TTM)29.95x
EPS Growth TTM (YoY)19.81%
Year-to-Date Return-12.59%
5-Day Price Return5.80%
EPS Normalized (Annual)$0.82
ROA (5Y Avg)2.19%
Net Profit Margin (Annual)5.79%
Month-to-Date Return-2.99%
Cash Flow / Share (TTM)$1.42
EBITD / Share (Annual)$1.36
Operating Margin (Annual)8.89%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)13.35x
ROI (5Y Avg)2.31%
P/E Excl Extra (TTM)29.95x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.83
P/TBV (Quarterly)3.60x
P/B Ratio (Annual)2.96x
Inventory Turnover (TTM)9.92x
Pretax Margin (TTM)9.51%
Book Value / Share (Annual)$9.76
Price vs S&P 500 (13W)-15.82%
Beta0.93x
P/FCF (Annual)14.20x
Revenue / Share (TTM)$14.16
ROE (TTM)9.26%
52-Week Low$8.61
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.09
4.18
4.18
4.18
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
TCMDTactile Systems Technology, Inc. | 1.74x | 11.99% | 50.79% | 8.89% | $25.13 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Tactile Systems Technology develops home-based medical devices for chronic disease management. The company's proprietary platforms include FlexiTouch for lymphedema treatment and AcuTouch for chronic venous insufficiency, along with additional solutions for chronic swelling. These wearable and home-based therapies enable patients to manage their conditions outside clinical settings.